Mengyao Xu
Papers
1
Total Citations
7
H-Index
1
About
Mengyao Xu is a clinical researcher whose work centers on advancing surgical outcomes for prostate cancer, with a particular focus on robotic-assisted techniques. Her most cited study, a 2024 systematic review and network meta-analysis, rigorously evaluates robotic-assisted radical prostatectomy (RARP) against open and laparoscopic approaches for localized prostate cancer. This work synthesizes evidence from multiple trials to clarify the comparative benefits of RARP, including reduced blood loss and shorter recovery times, while addressing ongoing debates about oncological and functional outcomes. With 7 citations already, the paper reflects growing interest in minimally invasive urologic oncology. Xu’s contributions help guide clinical decision-making by providing surgeons and patients with clearer data on surgical options. Her research underscores the importance of evidence-based evaluation in an era of rapid technological adoption, offering a balanced perspective on the trade-offs between innovation and established methods. For students and researchers in urology and surgical oncology, Xu’s work exemplifies how systematic reviews can translate complex clinical data into actionable insights, shaping best practices in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1